Pulmonary Delivery of Recombinant Human Bleomycin Hydrolase Using Mannose-Modified Hierarchically Porous UiO-66 for Preventing Bleomycin-Induced Pulmonary Fibrosis
ACS Applied Materials & Interfaces · 08.03.2023 · 15 (9) · 11520-11535
DOI: 10.1021/acsami.2c20479 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 21.02.2023. Verfasst von Jingxuan Cui und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China. Hauptthemen laut MEDLINE: Pulmonary Fibrosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Science and Technology Project of Haihe Laboratory of Modern Chinese Medicine.
Abstract (Originalsprache)
Bleomycins (BLMs) are widely used in clinics as antitumor agents. However, BLM-based chemotherapies often accompany severe pulmonary fibrosis (PF). Human bleomycin hydrolase is a cysteine protease that can convert BLMs into inactive deamido-BLMs. In this study, mannose-modified hierarchically porous UiO-66 (MHP-UiO-66) nanoparticles (NPs) were used to encapsulate the recombinant human bleomycin hydrolase (rhBLMH). When rhBLMH@MHP-UiO-66 was intratracheally instilled into the lungs, the NPs were transported into the epithelial cells, and rhBLMH prevented the lungs from PF during BLM-based chemotherapies. Encapsulation of rhBLMH in the MHP-UiO-66 NPs protects the enzyme from proteolysis in physiological conditions and enhances cellular uptake. In addition, the MHP-UiO-66 NPs significantly enhance the pulmonary accumulation of intratracheally instilled rhBLMH, thus providing more efficient protection of the lungs against BLMs during the chemotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
- Haihe Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
- Chemical Engineering Research Center, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China.
- Key Laboratory of Advanced Energy Materials Chemistry (MOE), Haihe Laboratory of Sustainable Chemical Transformations (Tianjin), Renewable Energy Conversion and Storage Center, College of Chemistry, Nankai University, T…
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
- Evidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
ORCID-Profile: Xiao Liu, Xiaohui Yan
Förderung
- Science and Technology Project of Haihe Laboratory of Modern Chinese Medicine
Zitieren
APA
Cui, J., Zhang, C., Liu, H., Yang, L., Liu, X., Zhang, J., Zhou, Y., Zhang, J., & Yan, X. (2023). Pulmonary Delivery of Recombinant Human Bleomycin Hydrolase Using Mannose-Modified Hierarchically Porous UiO-66 for Preventing Bleomycin-Induced Pulmonary Fibrosis. ACS Applied Materials & Interfaces, 15(9), 11520-11535. https://doi.org/10.1021/acsami.2c20479
Vancouver
Cui J, Zhang C, Liu H, Yang L, Liu X, Zhang J, et al. Pulmonary Delivery of Recombinant Human Bleomycin Hydrolase Using Mannose-Modified Hierarchically Porous UiO-66 for Preventing Bleomycin-Induced Pulmonary Fibrosis. ACS Applied Materials & Interfaces. 2023;15(9):11520-11535. doi:10.1021/acsami.2c20479
BibTeX
@article{Cui2023,
author = {Cui, Jingxuan and Zhang, Chengyu and Liu, Hongliang and Yang, Lijun and Liu, Xiao and Zhang, Jingjing and Zhou, Ying and Zhang, Junhua and Yan, Xiaohui},
title = {Pulmonary Delivery of Recombinant Human Bleomycin Hydrolase Using Mannose-Modified Hierarchically Porous UiO-66 for Preventing Bleomycin-Induced Pulmonary Fibrosis},
journal = {ACS Applied Materials & Interfaces},
year = {2023},
volume = {15},
number = {9},
pages = {11520--11535},
doi = {10.1021/acsami.2c20479}
}
EUVIMED